Of the 12 patients with available genetic information, germline features were as follows: 2 germline p53 (Li Fraumeni), 1 Gorlin syndrome, 1 germline RB mutation and 1 patient with hemihypertrophy but without confirmatory genetic testing. This evidence concerns the gene RB1 and nevoid basal cell carcinoma syndrome.